37.00
price down icon0.07%   -0.03
 
loading
Precedente Chiudi:
$37.03
Aprire:
$37
Volume 24 ore:
160.40K
Relative Volume:
0.32
Capitalizzazione di mercato:
$1.84B
Reddito:
$499.95M
Utile/perdita netta:
$-36.36M
Rapporto P/E:
-48.05
EPS:
-0.77
Flusso di cassa netto:
$24.22M
1 W Prestazione:
+1.47%
1M Prestazione:
+2.91%
6M Prestazione:
+15.35%
1 anno Prestazione:
+26.90%
Intervallo 1D:
Value
$36.74
$37.83
Intervallo di 1 settimana:
Value
$34.65
$37.83
Portata 52W:
Value
$27.64
$43.11

Atricure Inc Stock (ATRC) Company Profile

Name
Nome
Atricure Inc
Name
Telefono
513-755-4100
Name
Indirizzo
7555 INNOVATION WAY, MASON, OH
Name
Dipendente
1,300
Name
Cinguettio
@AtriCure
Name
Prossima data di guadagno
2024-10-29
Name
Ultimi documenti SEC
Name
ATRC's Discussions on Twitter

Confronta ATRC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
ATRC
Atricure Inc
36.98 1.76B 499.95M -36.36M 24.22M -0.77
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
435.50 156.44B 9.15B 2.63B 1.99B 7.1661
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
183.52 53.99B 21.39B 1.61B 2.55B 5.5609
Medical Instruments & Supplies icon
RMD
Resmed Inc
270.14 39.41B 5.15B 1.40B 1.65B 9.5082
Medical Instruments & Supplies icon
ALC
Alcon Inc
75.24 36.63B 10.03B 1.07B 1.39B 2.1549
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
265.90 18.78B 2.96B 487.70M 344.00M 6.6758

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-17 Ripresa JP Morgan Overweight
2024-04-23 Aggiornamento Oppenheimer Perform → Outperform
2023-10-23 Iniziato JMP Securities Mkt Outperform
2023-09-29 Iniziato UBS Buy
2021-08-05 Downgrade Oppenheimer Outperform → Perform
2020-12-18 Reiterato Needham Buy
2020-11-06 Reiterato Needham Buy
2020-04-07 Iniziato Oppenheimer Outperform
2020-02-06 Iniziato BTIG Research Buy
2020-01-24 Reiterato Needham Buy
2019-08-13 Downgrade Northland Capital Outperform → Market Perform
2019-04-12 Iniziato JP Morgan Overweight
2018-10-04 Reiterato Needham Buy
2018-08-02 Reiterato Needham Buy
2018-08-02 Reiterato Stifel Buy
2018-06-18 Reiterato Needham Buy
2018-04-27 Reiterato Needham Buy
2018-01-16 Reiterato Needham Buy
2017-11-02 Reiterato Needham Buy
2017-07-28 Reiterato Needham Buy
2017-05-30 Ripresa Piper Jaffray Overweight
2016-06-30 Ripresa JMP Securities Mkt Outperform
2015-10-28 Reiterato Needham Buy
2015-10-06 Reiterato Canaccord Genuity Buy
2015-10-06 Reiterato Needham Buy
Mostra tutto

Atricure Inc Borsa (ATRC) Ultime notizie

pulisher
Oct 15, 2025

Will AtriCure Inc. see short term momentumQuarterly Performance Summary & Technical Pattern Based Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How to build a dashboard for AtriCure Inc. stockWeekly Trade Summary & Weekly High Return Forecasts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Applying Elliott Wave Theory to AtriCure Inc.Volume Spike & Risk Managed Trade Strategies - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Analyzing AtriCure Inc. with multi timeframe chartsChart Signals & Entry Point Confirmation Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Is AtriCure Inc. stock trading near support levelsEntry Point & AI Powered Market Entry Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Momentum divergence signals in AtriCure Inc. chartWeekly Market Report & AI Optimized Trade Strategies - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Analyzing drawdowns of AtriCure Inc. with statistical toolsLong Setup & AI Forecasted Entry/Exit Points - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Did Analyst Optimism After Q3 Results Just Shift AtriCure's (ATRC) Path to Profitability Narrative? - simplywall.st

Oct 11, 2025
pulisher
Oct 11, 2025

AtriCure, Inc. (NASDAQ:ATRC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Reversal indicators forming on AtriCure Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

AtriCure's (ATRC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

AtriCure to Announce Third Quarter 2025 Financial Results - Business Wire

Oct 08, 2025
pulisher
Oct 08, 2025

AtriCure, Inc.'s (NASDAQ:ATRC) Shift From Loss To Profit - 富途牛牛

Oct 08, 2025
pulisher
Oct 07, 2025

AtriCure (NASDAQ:ATRC) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Marks Group Wealth Management Inc Increases Stock Position in AtriCure, Inc. $ATRC - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Order flow analysis tools used on AtriCure Inc.July 2025 Sector Moves & Verified Short-Term Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Can AtriCure Inc. hit a new high this monthWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is now a turning point for AtriCure Inc.July 2025 Catalysts & Real-Time Market Trend Scan - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Medtronic wins CE mark for Penditure LAA exclusion device - MedTech Dive

Oct 03, 2025
pulisher
Oct 01, 2025

AtriCure (NASDAQ:ATRC) Trading Down 4.9%What's Next? - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial Fibrillation - American Heart Association Journals

Sep 30, 2025
pulisher
Sep 30, 2025

What analysts say about AtriCure Inc stockFlag and Pennant Patterns & Wealth Building Starts With One Click - earlytimes.in

Sep 30, 2025
pulisher
Sep 27, 2025

AtriCure, Inc. $ATRC Stake Reduced by Assenagon Asset Management S.A. - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

AtriCure (NASDAQ:ATRC) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

U.S. Cryoablation Devices Market Set to Witness Significant Growth by 2025-2032 - openPR.com

Sep 26, 2025
pulisher
Sep 25, 2025

AtriCure to anchor Mason’s new bioscience corridor, add 25 jobs - soapboxmedia.com

Sep 25, 2025
pulisher
Sep 23, 2025

What Are the Top 8 Left Atrial Appendage Closure Device Companies in 2025 and How Are They Shaping the Industry? - Global Growth Insights

Sep 23, 2025
pulisher
Sep 23, 2025

AtriCure (ATRC) Valuation in Focus Following FDA Clearance and Launch of Next-Gen cryoXT Platform - Sahm

Sep 23, 2025
pulisher
Sep 22, 2025

AtriCure, Inc. $ATRC Shares Sold by Rhumbline Advisers - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Will a bounce in AtriCure Inc. offer an exitJuly 2025 Review & Weekly High Potential Stock Alerts - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Is AtriCure's cryoXT FDA Clearance Reshaping the Investment Case for ATRC? - simplywall.st

Sep 21, 2025
pulisher
Sep 21, 2025

First Bank & Trust Makes New Investment in AtriCure, Inc. $ATRC - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Street Watch: Will AtriCure Inc outperform the market in YEARJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

AtriCure, Inc. (NASDAQ:ATRC) Receives $50.89 Consensus Price Target from Analysts - MarketBeat

Sep 20, 2025

Atricure Inc Azioni (ATRC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$14.60
price up icon 5.05%
medical_instruments_supplies BAX
$22.98
price up icon 0.86%
$71.05
price down icon 0.71%
medical_instruments_supplies COO
$70.33
price up icon 2.28%
$68.09
price up icon 1.59%
medical_instruments_supplies WST
$265.90
price up icon 1.00%
Capitalizzazione:     |  Volume (24 ore):